Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...

Last week, families of children and young adults with Progeria welcomed the news that we are one step closer to the first approved treatment for this ultra-rare, devastating condition that causes ...

New research published in JAMA reports that lonafarnib, a farnesyltransferase inhibitor (FTI), extended survival in patients with Hutchinson-Gilford progeria syndrome (HGPS), or progeria. New research ...

Sentynl will acquire full rights to Progerinin for HGPS, provided certain milestones are achieved.

Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products AHMEDABAD, India and SOLANA ...

Biomedical engineers at Duke University constructed an advanced disease model for blood vessels prompting insights into Hutchinson-Gilford progeria syndrome, according to a study published in Stem ...

In the spring of 2005, families affected by progeria welcomed the news from two studies that uncovered new information about this rare, devastating condition that causes premature aging in children.

Partnership marks a critical step toward clinical development of an AAV gene therapy using a base editing approach designed to target the genetic cause of Hutchinson-Gilford Progeria Syndrome Forge ...

TOLEDO, Ohio The odds are unbelievable. With only 18 cases in the U.S. and 80 known cases in the entire world, that 80th case is a Whitehouse one-year-old who lives not quite a stone's throw from ...

Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present ...